Page last updated: 2024-08-23

spiradoline and Disease Models, Animal

spiradoline has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV	1
Wadenberg, ML	1
Fowler, CJ; Tiger, G	1
Ingenito, AJ; Shen, S	1
Maslov, LN; Naryzhnaya, NV; Tam, SW	1

Reviews

1 review(s) available for spiradoline and Disease Models, Animal

Article	Year
A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS drug reviews, 2003,Summer, Volume: 9, Issue:2 Topics: Analgesia; Analgesics; Animals; Cardiovascular System; Cocaine-Related Disorders; Disease Models, Animal; Diuresis; Dopamine; Drug Evaluation, Preclinical; Histamine; Humans; In Vitro Techniques; Neurosecretory Systems; Pyrrolidines; Receptors, Opioid, kappa; Tourette Syndrome	2003

Article

Year

A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.

CNS drug reviews, 2003,Summer, Volume: 9, Issue:2

Topics: Analgesia; Analgesics; Animals; Cardiovascular System; Cocaine-Related Disorders; Disease Models, Animal; Diuresis; Dopamine; Drug Evaluation, Preclinical; Histamine; Humans; In Vitro Techniques; Neurosecretory Systems; Pyrrolidines; Receptors, Opioid, kappa; Tourette Syndrome

2003

Other Studies

4 other study(ies) available for spiradoline and Disease Models, Animal

Article	Year
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49 Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection	2020
Comparison of the effects of a series of kappa-opioid receptor agonists upon sodium channel function in rat brain miniprisms. Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology, 1997, Volume: 117, Issue:1 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzeneacetamides; Benzomorphans; Brain; Disease Models, Animal; Inositol Phosphates; Naloxone; Pyrrolidines; Rats; Receptors, Opioid, kappa; Sodium Channels	1997
Depressor effect of kappa opioid agonist on hypertension induced by isolation in the rat. Clinical and experimental hypertension (New York, N.Y. : 1993), 1999, Volume: 21, Issue:3 Topics: Anesthesia; Animals; Blood Pressure; Disease Models, Animal; Heart Rate; Hippocampus; Hypertension; Injections, Intraperitoneal; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Social Isolation	1999
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life sciences, 1999, Volume: 65, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; beta-Endorphin; Disease Models, Animal; Dynorphins; Enkephalin, Leucine-2-Alanine; Heart; Immobilization; Ligands; Morphine; Myocardial Infarction; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Piperidines; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, delta; Stress, Physiological; Ventricular Fibrillation	1999